FDA Investigates Distributor August Egg Company After A Salmonella Outbreak
The FDA has warned consumers not to sell, serve or eat the distributor August Egg Company’s brown cage free and brown certified organic chicken eggs—1.7 million of them been recalled. The recalled eggs should no longer be placed on sale. They were sold under many different brand names at stores and restaurants; brands affected include Sunnyside, Sun Harvest, Raleys, Marketside, O Organics, Nulaid, First Street, and Clover. If you were made sick by recalled eggs, call the experienced Chicago-based food safety lawyers Moll Law Group about your case. Billions have been recovered in cases with which we’ve been involved all around the nation.
Contact the Seasoned Lawyers of Moll Law Group
The FDA and CDC are looking into illnesses in an outbreak of Salmonella Enteritidis infections that has been associated with the brown cage free eggs and brown certified organic eggs. The CDC found that 79 people in seven states have reported Salmonella infections believed to be from the outbreak. The illnesses occurred between February 24, 2025-May 17, 2025. There have been 21 hospitalizations but no known deaths.
The FDA found that the August Egg Company was the common supplier among the reported cases and collected samples at the company’s processing facility. Two of the collected samples were positive for Salmonella and matched the strain of Salmonella in the outbreak. The company sent its eggs to an egg breaking facility to get rid of the chance of Salmonella in May 2025. It’s also agreed to recall all the affected eggs that might be in people’s houses.
Illinois Injury and Mass Tort Lawyer Blog





Seasonal allergies are triggered by pollen and blooming flowers and other plants. Allergy symptoms include runny noses, itchy eyes, sneezing, and sometimes coughing. Patients have been prescribed medications, and in some cases, take over-the-counter allergy medication.
On May 1, 2025, SharkNinja Foodi OP Series Multi-Function Pressure Cookers were
Two Alzheimer’s drugs Leqembi and Kisunla were approved by the FDA to treat mild dementia or a pre-Alzheimer’s condition called mild cognitive impairment. Data had suggested that Leqembi could slow cognitive decline in Alzheimer’s patients by five months over a period of 18 months for patients who had only mild symptoms. Two thousand volunteers had agreed to test Leqembi in clinical studies. However, it turns out these drugs may also increase the risk for brain bleeds and swelling in patients with certain genetic profiles—and patients may not have been given
On February 20, 2025, Super 73
Recently, the Food and Drug Administration issued a
The Triumph TF250-X Off-Road Motorcycle, which is imported by Triumph Motorcycles America, has been
Recently, after a three-week trial, jurors in a state court
Recently, ICU Medical, Inc.
4, the Chicago-based company Riverside Natural Foods